I've forgotten who, but over a year ago somebody here pointed out the downsides of a NASDAQ listing and the failure in many a case to produce a sustained sp rise while adding to costs. Unless somebody digs into the history of such listings as that poster did, we only hear of the great success stories, of course. I'm happy to see PAA keep its nerve and hold course. It's steadily advancing on its goals and they're now coming into sight imo.
Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL, page-92
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $91.22M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 20.5¢ | $174.5K | 841.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 458470 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 144453 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |